MDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress disorder and alcohol use disorder.

Morley KC, Arunogiri S, Mills K, Watt J, Teesson M, Baillie A, Lee YY, Morse A, Back SE, Lubman DI, Haber PS

Open source

DOI
10.1136/bmjopen-2025-114896
Published
2026 Jul 6
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2025-114896,
  title = {MDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress disorder and alcohol use disorder.},
  author = {Morley KC and Arunogiri S and Mills K and Watt J and Teesson M and Baillie A and Lee YY and Morse A and Back SE and Lubman DI and Haber PS},
  year = {2026},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2025-114896},
  url = {https://doi.org/10.1136/bmjopen-2025-114896}
}

RIS

TY  - JOUR
TI  - MDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress disorder and alcohol use disorder.
AU  - Morley KC
AU  - Arunogiri S
AU  - Mills K
AU  - Watt J
AU  - Teesson M
AU  - Baillie A
AU  - Lee YY
AU  - Morse A
AU  - Back SE
AU  - Lubman DI
AU  - Haber PS
PY  - 2026
JO  - BMJ open
DO  - 10.1136/bmjopen-2025-114896
UR  - https://doi.org/10.1136/bmjopen-2025-114896
ER  - 

APA

KC, M., S, A., K, M., J, W., M, T., A, B., YY, L., A, M., SE, B., DI, L., & PS, H. (2026). MDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress disorder and alcohol use disorder.. BMJ open. https://doi.org/10.1136/bmjopen-2025-114896

Source records